XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Income - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Condensed Consolidated Statements of Income [Abstract]        
Net sales $ 161,810,000 $ 122,568,000 $ 486,392,000 $ 372,654,000
Cost of goods sold 129,235,000 98,327,000 394,295,000 295,300,000
Gross profit 32,575,000 24,241,000 92,097,000 77,354,000
Operating expenses:        
General and administrative 14,605,000 14,005,000 41,556,000 38,210,000
Sales and marketing 6,274,000 4,698,000 17,162,000 13,224,000
Research and development 2,635,000 2,100,000 7,631,000 6,014,000
Foreign exchange impact of lease liabilities and forward contracts 385,000 (12,455,000) 1,769,000 (21,257,000)
Total operating expenses 23,899,000 8,348,000 68,118,000 36,191,000
Operating income 8,676,000 15,893,000 23,979,000 41,163,000
Interest expense, net 3,949,000 4,051,000 11,510,000 12,074,000
Income before income tax expense 4,727,000 11,842,000 12,469,000 29,089,000
Income tax expense 1,588,000 3,373,000 4,786,000 8,448,000
Net income $ 3,139,000 $ 8,469,000 $ 7,683,000 $ 20,641,000
Basic net income per share (in dollars per share) $ 0.16 $ 0.44 $ 0.40 $ 1.09
Diluted net income per share (in dollars per share) $ 0.16 $ 0.44 $ 0.39 $ 1.07
Weighted average number of shares outstanding:        
Basic (in shares) 19,184,339 19,053,232 19,124,824 19,016,302
Diluted (in shares) 19,544,174 19,436,793 19,604,780 19,333,758